PD-L1 expression on circulating tumor cells for predicting clinical outcomes in patients with hepatocellular carcinoma receiving PD-(L)1 blockade and targeted therapy.

J Immunother Cancer · 2026 · PMC12853561 · PMID 41611241

Europe PMC DOI

hedged sentence

0.0760

closest p · 1.5× alpha

0.0760

boldest claim

The sentences

did not reach statistical significancep=0.076so close (0.05 < p ≤ 0.1)

While OS also showed a similar trend, the difference did not reach statistical significance (median OS: 13.77 months vs 34.60 months; p=0.076; figure 1C ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.